Cargando…

Effect of Impella 5.5 on Preexisting Functional Mitral Regurgitation in Patients with Heart Failure–Related Cardiogenic Shock

BACKGROUND: Heart failure–related cardiogenic shock (HF-CS) is increasingly common. Moderate/severe functional mitral regurgitation (FMR) is commonly seen in patients presenting with decompensated heart failure and is associated with worse outcomes. Percutaneous mechanical circulatory support device...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kataria, Rachna, Khalil, Abdurrahman, Coglianese, Erin, Crowley, Jerome, Silverman, Michael G., Shelton, Kenneth, Michel, Eriberto, D’Alessandro, David, Ton, Van-Khue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242560/ https://www.ncbi.nlm.nih.gov/pubmed/37288332 http://dx.doi.org/10.1016/j.shj.2022.100072

Ejemplares similares

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

Case report: management of refractory cardiogenic shock with Impella 5.5 in patients with transcatheter aortic valves
por: Harada, Rakushumimarika, et al.
Publicado: (2023)

Transinnominate Impella 5.5 insertion as a bridge to transplantation in a pediatric patient in refractory cardiogenic shock
por: Bouhout, Ismail, et al.
Publicado: (2022)

Single center experience and early outcomes of Impella 5.5
por: Funamoto, Masaki, et al.
Publicado: (2023)

Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock
por: Madjarov, Jeko M., et al.
Publicado: (2021)

Successful Treatment of Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction and Acute Mitral Regurgitation by Impella CP
por: Benak, Ales, et al.
Publicado: (2022)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Aortic Valve Leaflet Disruption: A Severe Complication of Impella 5.5
por: Ghannam, Alexander D, et al.
Publicado: (2021)

Successful extended use of Impella 5.5 as a bridge to heart transplantation
por: Sharaf, Omar M, et al.
Publicado: (2023)

ST-Elevation Myocardial Infarction With Cardiogenic Shock and Severe Acute Ischemic Mitral Regurgitation Rescued by Primary Coronary Intervention Under Hemodynamic Support With Impella
por: Koiwaya, Hiroshi, et al.
Publicado: (2021)

A “Grave” Case of Mitral Regurgitation: Cardio-Obstetric Approach to Severe Mitral Regurgitation With Cardiogenic Shock
por: Isath, Ameesh, et al.
Publicado: (2022)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility
por: Roka-Moiia, Yana, et al.
Publicado: (2020)

Unilateral cardiogenic pulmonary edema associated with acute mitral regurgitation
por: Kashiura, Masahiro, et al.
Publicado: (2016)

Cardiogenic shock due to acute severe ischemic mitral regurgitation
por: Briosa e Gala, Andre, et al.
Publicado: (2021)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation
por: Attisano, Tiziana, et al.
Publicado: (2020)

Single center first year experience and outcomes with Impella 5.5 left ventricular assist device
por: Rock, Joanna R., et al.
Publicado: (2022)

Short‐term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device
por: Haddad, Osama, et al.
Publicado: (2023)

Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults
por: Rahimi, Kazem, et al.
Publicado: (2017)

Cardiogenic Pneumonia: Unilateral Pulmonary Edema Secondary to Severe Eccentric Mitral Regurgitation
por: Rouzbehani Selakhor, Jahangir, et al.
Publicado: (2023)

A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre
por: Kennel, Peter J., et al.
Publicado: (2021)

Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis
por: George, Praveen, et al.
Publicado: (2017)

Impella 5.0/5.5 Implantation via Innominate Artery: Further Expanding the Opportunities for Temporary Mechanical Circulatory Support
por: Bertolin, Stephanie, et al.
Publicado: (2022)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock
por: Ogawa, Shou, et al.
Publicado: (2019)

Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France
por: Le Guyader, Alexandre, et al.
Publicado: (2021)

Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic
por: Chitturi, Kalyan R., et al.
Publicado: (2020)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_amsude731qrif7fjrcuhpbj8q1